首页> Blood> Complex karyotype in unfit patients with CLL treated with ibrutinib and rituximab: the GIMEMA LLC1114 phase 2 study.

Complex karyotype in unfit patients with CLL treated with ibrutinib and rituximab: the GIMEMA LLC1114 phase 2 study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Gian Matteo,Rigolin

第一单位： Hematology Section, St Anna University Hospital, Ferrara, Italy.

作者： Gian Matteo,Rigolin ^[1] ; Ilaria,Del Giudice ^[2] ; Antonella,Bardi ^[1] ; Aurora,Melandri ^[1] ; Rocio Edith,García-Jacobo ^[1] ; Francesca,Cura ^[1] ; Sara,Raponi ^[2] ; Caterina,Ilari ^[2] ; Luciana,Cafforio ^[2] ; Alfonso,Piciocchi ^[3] ; Valentina,Arena ^[3] ; Gianluigi,Reda ^[4] ; Francesco,Albano ^[5] ; Stefano,Molica ^[6] ; Paolo,Sportoletti ^[7] ; Livio,Trentin ^[8] ; Monia,Marchetti ^[9] ; Mauro,Nanni ^[2] ; Nadia,Peragine ^[2] ; Paola,Mariglia ^[2] ; Marco,Vignetti ^[3] ; Anna,Guarini ^[10] ; Francesca Romana,Mauro ^[2] ; Robin,Foà ^[2] ; Antonio,Cuneo ^[1]

作者单位： Hematology Section, St Anna University Hospital, Ferrara, Italy. ^[1] Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy. ^[2] Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Data Center, GIMEMA Foundation, Rome, Italy. ^[3] Hematology Unit, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy. ^[4] Hematology Section, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy. ^[5] Hematology, Azienda Ospedaliera Pugliese Ciaccio, Catanzaro, Italy. ^[6] Institute of Hematology and Center for Hemato-Oncological Research, Ospedale S Maria della Misericordia, University of Perugia, Perugia, Italy. ^[7] Hematology Unit, University of Padua, Padua, Italy. ^[8] Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy; and. ^[9] Department of Molecular Medicine, Sapienza University, Rome, Italy. ^[10]